ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner
Jing Ye, Yuting Wu, Yao Chen, Yiyue Ren, Xiaohua Jiang, Zhihuai Dong, Jingna Zhang, Mao Jin, Xiaozhen Chen, Zhanggui Wang, Mang Xiao
Abstract
Abstract Hypopharyngeal squamous cell carcinoma (HPSCC) is one of the most aggressive cancers and is notorious for its extremely poor prognosis. However, very few molecular biological studies have been performed. As a novel method of epigenetic gene modulation, N6-methyladenosine (m 6 A) RNA modification occurs in HPSCC. The expression of the m 6 A demethylase AlkB homolog 5 (ALKBH5) is frequently downregulated in human HPSCC. Furthermore, we found that ALKBH5 impaired cell proliferation by regulating human Toll-like receptor 2 (TLR2) in an m 6 A-dependent manner in HPSCC cells. ALKBH5 decreased TLR2 m 6 A modification, which could be recognized by the m 6 A readers IGF2BP2 and YTHDF1. IGF2BP2 facilitates TLR2 mRNA stability, whereas YTHDF1 promotes TLR2 mRNA translation. The current work uncovered a critical function of ALKBH5 in TLR2 regulation and provides a novel role for m 6 A demethylation of mRNA in HPSCC. The inhibition of m 6 A modification of ALKBH5 in HPSCC deserves further clinical investigation.